Following U.S. Stocks may claim a “BIG Change,” in the course of current trading session: Catamaran Corp (USA) (NASDAQ:CTRX), UnitedHealth Group Inc (NYSE:UNH)
- Catamaran Corp (USA) (NASDAQ:CTRX), with shares climbed 24.10% is now trading at $59.98, hitting new 52-week high of $60.24. The Stock is active as 14.34M shares changed hands versus its average volume of 1.82M shares.
- UnitedHealth Group Inc (NYSE:UNH), with shares raised 3.19% is now trading at $121.78, hitting new 52-week high of $123.76. The Stock is active as 1.24M shares changed hands versus its average volume of 3.75M shares.
Latest NEWS regarding these Stocks are depicted underneath:
Today, Catamaran Corporation (CTRX), and OptumRx declared they have agreed to combine. OptumRx is UnitedHealth Group’s (NYSE:UNH), free-standing pharmacy care services business.
The contract calls for the attainment of Catamaran’s outstanding ordinary stock for $61.50 per share in cash. The transaction is predictable to close during the fourth quarter of 2015, subject to Catamaran shareholders’ approval, regulatory approvals and other customary closing conditions. The combination diversifies OptumRx’s customer and business mix, while accelerating its technology leadership and flexible service offerings.
The attainment is predictable to be accretive to UnitedHealth Group’s net earnings in the area of $0.30 per share in 2016. UnitedHealth Group plans to finance the attainment from existing cash resources and new debt. The corporation affirmed its $6.00 to $6.25 per share earnings outlook assuming the absorption of all merger costs, the ongoing commitment to advance its dividend policy as planned, and a continued but moderated level of share repurchase.
OptumRx and Catamaran will create noteworthy value for their combined customer base beyond the scale and improved service resulting from integration of their businesses. This combination is predictable to create a dynamic competitor in the PBM market by combining the strengths of Catamaran’s industry-leading technology platform with the data and analytics capabilities of Optum. The combined corporation is predictable to deliver an innovative and compelling consumer and payer services offering that will link demographic, lab, pharmaceutical, behavioral and medical treatment data to engage individuals to make better decisions as they seek the best, most effective care and improve compliance with pharmaceutical use and care protocols.
Both companies have distinctive, rapidly growing specialty pharmacy services businesses. The combined organization will assist customers manage the complex costs and outcomes as this portion of the pharmaceutical market expands from an estimated $100 billion in proceeds in 2014 to potentially $400 billion annually by 2020.
Catamaran Corporation provides pharmacy benefit administration (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits administration industry in North America.
UnitedHealth Group Incorporated operates as a diversified health and well-being corporation in the United States. The corporation’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
